| Literature DB >> 28322476 |
Ingmar Heinig1, Andre Pittig1, Jan Richter2, Katrin Hummel1, Isabel Alt3, Kristina Dickhöver4, Jennifer Gamer4, Maike Hollandt2, Katja Koelkebeck5, Anne Maenz6, Sophia Tennie6, Christina Totzeck7, Yunbo Yang8, Volker Arolt5, Jürgen Deckert9, Katharina Domschke9,10, Thomas Fydrich11, Alfons Hamm2, Jürgen Hoyer1, Tilo Kircher8, Ulrike Lueken9, Jürgen Margraf7, Peter Neudeck12, Paul Pauli4, Winfried Rief6, Silvia Schneider7, Benjamin Straube8, Andreas Ströhle3, Hans-Ulrich Wittchen1.
Abstract
Exposure-based psychological interventions currently represent the empirically best established first line form of cognitive-behavioural therapy for all types of anxiety disorders. Although shown to be highly effective in both randomized clinical and other studies, there are important deficits: (1) the core mechanisms of action are still under debate, (2) it is not known whether such treatments work equally well in all forms of anxiety disorders, including comorbid diagnoses like depression, (3) it is not known whether an intensified treatment with more frequent sessions in a shorter period of time provides better outcome than distributed sessions over longer time intervals. This paper reports the methods and design of a large-scale multicentre randomized clinical trial (RCT) involving up to 700 patients designed to answer these questions. Based on substantial advances in basic research we regard extinction as the putative core candidate model to explain the mechanism of action of exposure-based treatments. The RCT is flanked by four add-on projects that apply experimental neurophysiological and psychophysiological, (epi)genetic and ecological momentary assessment methods to examine extinction and its potential moderators. Beyond the focus on extinction we also involve stakeholders and routine psychotherapists in preparation for more effective dissemination into clinical practice.Entities:
Keywords: anxiety disorders; exposure therapy; extinction; randomized clinical trial
Mesh:
Year: 2017 PMID: 28322476 PMCID: PMC6877126 DOI: 10.1002/mpr.1560
Source DB: PubMed Journal: Int J Methods Psychiatr Res ISSN: 1049-8931 Impact factor: 4.035